At least 30% reported pain reduction was recorded in approximately 65% of duloxetine treated patients versus 40% for placebo.
Vähemalt 30% teatatud valu vähenemisest registreeriti umbes 65% - l duloksetiini ravi saanud patsientidel võrreldes 40% platseeboga ravitud patsientidest.